Vantage logo

Sobi strikes again

CTI Biopharma sees an unlikely end to its 32-year rollercoaster existence.

Vantage logo

Novartis trims its pipeline

Discontinuations for branaplam, iptacopan and Piqray could increase pipeline scepticism, but more pruning is coming.